Related Experiment Videos
[Cardiovascular manifestations of seronegative inflammatory spondyloarthropathies]
Hanna Przepiera-Bedzak1, Iwona Brzosko, Małgorzata Peregud-Pogorzelska
1Klinika Reumatologii i Chorób Wewnetrznych Pomorskiej Akademii Medycznej w Szczecinie ul. Unii Lubelskiej 1, 71-252 Szczecin.
Insights
Cardiovascular issues are common in seronegative spondyloarthropathies like ankylosing spondylitis and psoriatic arthritis. Early cardiac investigation is crucial for managing these patients and improving outcomes.
Area of Science:
- Rheumatology
- Cardiology
Context:
- Seronegative spondyloarthropathies (SnAs) encompass a group of inflammatory diseases.
- Cardiovascular involvement in SnAs is a significant clinical concern requiring further elucidation.
Purpose:
- To review and highlight the cardiovascular manifestations in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA).
- To emphasize the need for comprehensive cardiovascular assessment in SnA patients.
Summary:
- Ankylosing spondylitis (AS) patients exhibit various echocardiographic abnormalities including ascending aortitis, valvular insufficiency, and conduction system defects.
- Psoriatic arthritis (PsA) is associated with a higher mortality risk due to cardiovascular diseases, with reported abnormalities including pericarditis, myocarditis, and valvular disease.
- Diastolic dysfunction in PsA correlates with disease activity and duration.
Impact:
- Understanding these cardiac risks can lead to earlier diagnosis and intervention.
- Improved cardiovascular monitoring in SnA patients may reduce morbidity and mortality.
- This review underscores the importance of a multidisciplinary approach involving rheumatologists and cardiologists.
Abstract:
Cardiovascular manifestations of seronegative spondyloarthropathies represent an important clinical problem which has not been fully elucidated. Clinically significant cardiovascular symptoms are present in 10% of patients with ankylosing spondylitis (AS), usually in the case of long-standing disease. The following echocardiographic abnormalities have been reported in AS: ascending aortitis, aortic insufficiency (1-34%), mitral insufficiency (1-76%), mitral valve prolapse (5.7-10%), and diastolic dysfunction (20-50%). Abnormalities of the cardiac conduction system may develop in 1% to 33% of AS patients as a consequence of postinflammatory scarring of the myocardium. Cardiovascular diseases are the leading cause of death (36.2%) of patients with psoriatic arthritis (PsA). The risk of death in PsA is 1.3 times greater than in the general population. The following echocardiographic abnormalities can be seen in PsA: fibrinous pericarditis (18.2%), myocarditis (15.9%), and valvular disease (5.7%). Diastolic dysfunction in PsA correlates with the presence of articular lesions and duration of psoriasis. The importance of a thorough investigation of the cardiovascular system in patients with seronegative spondyloarthropathies is emphasized.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Inflammatory Bowel Disease IV: Clinical Manifestations